- What is Macular Degeneration? - AMDF
Macular Degeneration, also known as Age-related Macular Degeneration (AMD), is the leading cause of irreversible vision loss in adults over 60, affecting nearly 20 million Americans
- Learn About Types and Stages of Macular Degeneration
Learn about the two main types of age-related macular degeneration and the different stages of each type and how they progress
- Macular Degeneration Overview | Quick Summary by AMDF
Learn about macular degeneration and how it leads to vision loss in this quick, easy-to-understand, overview of age-related macular degeneration
- Care and Treatment Guides for Macular Degeneration
Find the right doctor, learn about macular degeneration treatment options, and learn about what you can do at home to monitor and reduce your risk
- About Macular Degeneration - Symptoms, Risks, and Diagnosis
Macular degeneration is a progressive eye disease that affects the tiny, central part of the retina called the macula at the back of the eye and can cause loss of central vision It is the leading cause of vision loss in people over 40
- The American Macular Degeneration Foundation (AMDF)
Here to help you learn about and live with Age-related Macular Degeneration (AMD), offering you healthy living tips, the latest information, and ways to honor those touched by macular disease, while supporting researchers working to prevent, treat and cure macular degeneration and Stargardt disease
- Dry Macular Degeneration Treatments - AMDF
Treatments are available for macular degeneration Learn more about your options by the stage of macular degeneration you have
- clinical trials | American Macular Degeneration Foundation
NORTHAMPTON, Ma , Dec 19, 2023 — The American Macular Degeneration Foundation received news that the first patient has been dosed in a safety and efficacy clinical trial of a one-time gene therapy treatment for advanced dry macular degeneration (dry AMD), also known as Geographic Atrophy (GA)
|